Hormonal

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA type-c

Preclinical
Share:

Buy in shop

MOTS-c from $74/kit

5 verified vendors, ≥99% purity, COAs included.

Compare prices

Key Facts: MOTS-c

Category
Hormonal
FDA Status
Not FDA Approved
Clinical Status
Preclinical - Early human studies beginning. FDA Category 2 (pending reclassification to Category 1 per April 15, 2026 HHS announcement; remains Category 2 under current law until formal FDA rule; PCAC review July 23-24, 2026)
Administration
Subcutaneous injection
Typical Dose
5-10 mg weekly
Frequency
1-3x weekly
Duration
Variable by protocol
Also Known As
Mitochondrial ORF of the 12S rRNA type-c

Mechanism of Action

MOTS-c works largely through the AMPK pathway, the cell's main energy and fuel-gauge system. The proposed route is that MOTS-c interferes with the folate-AICAR-one-carbon metabolism cycle, which raises AICAR and activates AMPK in skeletal muscle, liver, and fat. Once AMPK is switched on, cells burn more fatty acids, take up more glucose, and ramp up mitochondrial biogenesis. MOTS-c can also move into the cell nucleus under metabolic stress and influence stress-response genes, which is unusual for a mitochondrial peptide and is part of why it is framed as a stress-adaptive signal. Treat the exact pathway details as a working model rather than settled fact, since much of it is still being mapped.

Research Summary

In mice, MOTS-c is genuinely impressive: it improves insulin sensitivity, protects against diet-induced obesity, and older animals given MOTS-c run longer on a treadmill, which is where the exercise-mimetic label comes from. The human story is much thinner. The strongest human finding is observational: exercise raises MOTS-c, with reports of roughly a 12-fold jump in skeletal muscle and about a 1.6-fold rise in circulation after exercise, suggesting it may be one natural messenger behind some exercise benefits. But that is correlation, not proof that injecting MOTS-c reproduces those benefits. As of 2026 there are no completed, published randomized human trials showing that supplemental MOTS-c causes weight loss, better metabolic health, or longer life in people. It is also a known anti-doping target, which tells you it is treated as experimental and performance-relevant, not as an established therapy.

Trial Progress:Preclinical
Pre
I
II
III
IV
FDA

Dosing Information

Animal Studies·Primarily animal/preclinical research

Note: Animal study doses may not translate directly to humans.

Typical Dosing

Community experience

Common Dose

5-10 mg weekly

Range

5-15 mg per week

Frequency

1-3x weekly

Mitochondrial peptide for metabolic health. Take on exercise days. Often used 2-3x weekly.

Research Dosing

Scientific studies

Doses from research protocols

Duration

Variable by protocol

Administration

Subcutaneous injection

Timing & Administration

Best Time to Take

Morning or pre-workout

3-5 times per week

Food Recommendation

Take on empty stomach

Why This Timing?

MOTS-c enhances metabolic function and exercise capacity. Morning/pre-exercise timing optimizes benefits.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Generally well-tolerated
  • Injection site reactions (persistent bumps)
  • Palpitations
  • Nausea and bloating
  • Fatigue
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
  • Potential interactions with metformin
  • Long-term effects unknown

References

Research This Peptide Further

Buy in shop

MOTS-c from $74/kit

5 verified vendors, ≥99% purity, COAs included.

Compare prices

Frequently Asked Questions

What does MOTS-c do?

MOTS-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12S rRNA region of mitochondrial DNA and discovered in 2015. It is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. The catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials.

How does MOTS-c work?

MOTS-c works largely through the AMPK pathway, the cell's main energy and fuel-gauge system. The proposed route is that MOTS-c interferes with the folate-AICAR-one-carbon metabolism cycle, which raises AICAR and activates AMPK in skeletal muscle, liver, and fat. Once AMPK is switched on, cells burn more fatty acids, take up more glucose, and ramp up mitochondrial biogenesis. MOTS-c can also move into the cell nucleus under metabolic stress and influence stress-response genes, which is unusual for a mitochondrial peptide and is part of why it is framed as a stress-adaptive signal. Treat the exact pathway details as a working model rather than settled fact, since much of it is still being mapped.

Is MOTS-c FDA approved?

No, MOTS-c is not currently FDA approved. Current status: Preclinical - Early human studies beginning. FDA Category 2 (pending reclassification to Category 1 per April 15, 2026 HHS announcement; remains Category 2 under current law until formal FDA rule; PCAC review July 23-24, 2026)

What are the side effects of MOTS-c?

Reported side effects include: Generally well-tolerated, Injection site reactions (persistent bumps), Palpitations, Nausea and bloating, Fatigue. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of MOTS-c?

Community-reported common dose: 5-10 mg weekly (1-3x weekly). Range: 5-15 mg per week. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with MOTS-c or used in similar applications.

Oxytocin

FDA

Oxytocin is a 9-amino-acid hormone made in the hypothalamus, famous as the chemistry behind labor contractions, breastfeeding, and social bonding. As an injectable drug it is FDA-approved to induce labor and control postpartum bleeding, but the intranasal 'love hormone' versions sold for trust, anxiety, and autism are experimental and the human results are genuinely mixed. The hype runs well ahead of the evidence.

Hormonal

Kisspeptin

Clinical Trials

Kisspeptin is the master switch that tells your brain to start reproduction. It is a family of peptides (the full length is kisspeptin-54, with shorter active fragments KP-14, KP-13, and KP-10) made from the KISS1 gene, and it acts as the upstream trigger for the entire reproductive hormone cascade. It is not an approved drug, but it has been tested in real human trials for fertility, hypothalamic amenorrhea, and male hypogonadism, with promising early results.

Hormonal

Gonadorelin

FDA

Gonadorelin is a synthetic copy of natural GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) that tells the pituitary to release LH and FSH. It is FDA-approved for evaluating pituitary function and has historical use in inducing ovulation. In the peptide world it is mostly used off-label to keep the testes working during testosterone replacement, and the catch is that timing matters enormously: pulse it and you stimulate, give it continuously and you shut the system down.

Hormonal

Leuprolide

FDA

Leuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide about 20 times more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug, not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.

Hormonal

Desmopressin

FDA

Desmopressin (dDAVP) is a synthetic tweak of the natural hormone vasopressin, redesigned to keep the water-retaining effect while dropping most of the blood-pressure effect. It is a long-established FDA-approved drug used for central diabetes insipidus, bedwetting and nocturia, and certain bleeding disorders like von Willebrand disease and mild hemophilia A. This is settled medicine, not an experimental peptide, and its main real-world danger is straightforward: it can drop your blood sodium dangerously low if you drink too much fluid on it.

Hormonal

Octreotide

FDA

Octreotide is a synthetic eight-amino-acid mimic of the natural hormone somatostatin, the body's main 'off switch' for hormone secretion. It shuts down excess growth hormone, so it is a frontline FDA-approved drug for acromegaly, and it also tames the flushing and diarrhea of hormone-secreting carcinoid and other neuroendocrine tumors. This is real, approved medicine with decades of clinical data behind it, sold as Sandostatin (injectable, since 1988), Sandostatin LAR (monthly depot), and Mycapssa (oral capsule, approved 2020).

Hormonal

Want updates on MOTS-c research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.